Barr COO leaves
This article was originally published in The Tan Sheet
Executive Summary
Barr Phamaceuticals' President and Chief Operating Officer Paul M. Bisaro announces Aug. 2 he is leaving the company to work for Watson Pharmaceuticals. Barr's Chairman and CEO Bruce L. Downey will assume Bisaro's responsibilities in the interim period. The Woodcliff Lake, N.J.-based firm says it is "confident that the departure will not have a negative effect on U.S. or international operations"...